National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) Announces the Following Meeting and Opening of the Public Comment Period, 77399-77400 [E5-8100]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 250 / Friday, December 30, 2005 / Notices
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry.
Dated: December 23, 2005.
Elaine Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 05–24639 Filed 12–29–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Institute for Occupational
Safety and Health Advisory Board on
Radiation and Worker Health
wwhite on PROD1PC61 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting:
Name: Working Group of the Advisory
Board on Radiation and Worker Health
(ABRWH), National Institute for
Occupational Safety and Health (NIOSH).
Audio Conference Call Time and Date: 10
a.m.–4 p.m., EST, Monday, January 9, 2006.
Place: Audio conference call via FTS
conferencing. The USA toll-free dial-in
number is 1–888–390–6586, pass code 41964.
Status: Open to the public, but without a
public comment period.
Background: The ABRWH was established
under the Energy Employees Occupational
Illness Compensation Program Act
(EEOICPA) of 2000 to advise the President,
delegated to the Secretary, Department of
Health and Human Services (HHS), on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Board include providing
advice on the development of probability of
causation guidelines which have been
promulgated by HHS as a final rule, advice
on methods of dose reconstruction which
have also been promulgated by HHS as a
final rule, advice on the scientific validity
and quality of dose estimation and
reconstruction efforts being performed for the
purposes of the compensation program, and
advice on petitions to add classes of workers
to the Special Exposure Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
VerDate Aug<31>2005
18:16 Dec 29, 2005
Jkt 208001
2001 and renewed at appropriate intervals,
and will expire on August 3, 2007.
Purpose: The Board is charged with (a)
providing advice to the Secretary, HHS, on
the development of guidelines under
Executive Order 13179; (b) providing advice
to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction
efforts performed for this program; and (c)
upon request by the Secretary, HHS, advise
the Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such radiation
doses may have endangered the health of
members of this class.
Matters to be Discussed: Agenda for the
conference call includes reviews of the
Bethlehem Steel Site Profile, Y–12 Site
Profile, a report from the working group
regarding discussions concerning the Board’s
review of SEC petitions, and science issues.
The agenda is subject to change as
priorities dictate.
In the event a member cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
For Further Information Contact: Dr. Lewis
V. Wade, Executive Secretary, NIOSH, CDC,
4676 Columbia Parkway, Cincinnati, Ohio
45226, telephone 513/533–6825, fax 513/
533–6826.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: December 22, 2005.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 05–24640 Filed 12–29–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Institute for Occupational
Safety and Health (NIOSH) of the
Centers for Disease Control and
Prevention (CDC) Announces the
Following Meeting and Opening of the
Public Comment Period
Name: The Draft Document: NIOSH
Current Intelligence
Bulletin: Evaluation of Health Hazard
and Recommendations for Occupational
Exposure to Titanium Dioxide.
Meeting Date and Time: February 27,
2006, 9 a.m.–4 p.m.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
77399
Place: Robert A. Taft Laboratories,
Taft Auditorium, NIOSH, CDC, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
Purpose: To explain and discuss the
scientific basis for the draft document,
‘‘NIOSH Current Intelligence Bulletin:
Evaluation of Health Hazard and
Recommendations for Occupational
Exposure to Titanium Dioxide,’’ current
research on titanium dioxide, and
information on occupational exposure
to titanium dioxide. Special emphasis
will be placed on discussion of the
following:
(1) What animal and human data best
describe the health concerns from
exposure to titanium dioxide; (2) What
strategies are being used to control
occupational exposure to titanium
dioxide (e.g., engineering controls, work
practices, personal protective
equipment); (3) In which workplaces
and occupations can exposure to
titanium dioxide occur; (4) What
challenges exist in measuring workplace
exposures to titanium dioxide; (5) What
are areas for future collaborative efforts
(e.g., research, communication,
development of exposure measurement
and control strategies)?
The public is invited to attend and
will have the opportunity to provide
comments.
NIOSH seeks to obtain materials,
including published and unpublished
reports and research findings, to
evaluate the possible health risks of
occupational exposure to titanium
dioxide (including particle size-specific
information). Examples of requested
information include, but are not to be
limited to, the following: (1)
Identification of industries or
occupations in which exposures to
titanium dioxide may occur; (2) Trends
in the production and use of titanium
dioxide; (3) Description of work tasks
and scenarios with a potential for
exposure to titanium dioxide; (4)
Current and historical exposure
measurement data in various types of
industries and jobs; (5) Case reports or
other health information demonstrating
health effects in workers exposed to
titanium dioxide; (6) Reports of
experimental in vivo and in vitro
studies that provide evidence of a doserelationship between the particle size of
a substance and its biological activity;
(7) Reports of experimental inhalation
studies with rodents demonstrating a
relationship between the particle size or
surface area of a substance and lung
inflammation, fibrosis, and biochemical
mediators; (8) Description of work
practices and engineering controls used
to reduce or prevent workplace
exposure to titanium dioxide. (9)
E:\FR\FM\30DEN1.SGM
30DEN1
wwhite on PROD1PC61 with NOTICES
77400
Federal Register / Vol. 70, No. 250 / Friday, December 30, 2005 / Notices
Educational materials for worker safety
and training on the safe handling of
titanium dioxide; (10) Data pertaining to
the feasibility of establishing particle
size-specific RELs for titanium dioxide.
NIOSH will use this information to
assess the scientific basis for the draft
worker health recommendations
contained in the draft Current
Intelligence Bulletin and determine the
need for revision to those draft
recommendations for reducing
occupational exposure to titanium
dioxide.
Status: The forum will include
scientists and representatives from
various government agencies, industry,
labor, and other stakeholders, and is
open to the public, limited only by the
space available. The meeting room
accommodates 80 people. Due to
limited space, notification of intent to
attend the meeting must be made to
Diane Miller no later than February 14,
2006. Ms. Miller can be reached by
telephone at 513/533–8450 or by e-mail
at niocindocket@cdc.gov. Requests to
attend the meeting will be
accommodated on a first-come basis.
Non-U.S. Citizens: Because of CDC
Security Regulations, any non-U.S.
citizen wishing to attend this meeting
must provide the following information
in writing to Diane Miller at the address
below no later than February 14, 2006:
(1) Visitor’s full name; (2) Gender; (3)
Date of Birth; (4) Place of birth (city,
province, state, country); (5)
Citizenship; (6) Passport number; (7)
Date of passport issue; (8) Date of
passport expiration; (9) Type of Visa;
(10) Visitor’s organization; (11)
Organization address; (12) Organization
telephone number; (13) Visitor’s
position/title within the organization.
This information will be transmitted
to the CDC Security Office for approval.
Visitors will be notified as soon as
approval has been obtained.
A copy of the draft Current
Intelligence Bulletin Evaluation of
Health Hazard and Recommendations
for Occupational Exposure to Titanium
Dioxide can be obtained from the
Internet at https://www.cdc.gov/niosh/
docs/preprint/tio2 or a hard copy may
be requested from the Docket Officer,
Diane Miller (contact information
below).
Addresses: Comments should be
submitted to the NIOSH Docket Office,
ATTN: Diane Miller, Robert A. Taft
Laboratories, 4676 Columbia Parkway,
M/S C–34, Cincinnati, Ohio 45226,
telephone 513/533–8450, fax 513/533–
8285.
Comments may also be submitted
directly through the Web site (https://
www.cdc.gov/niosh/docs/preprint/tio2)
VerDate Aug<31>2005
18:16 Dec 29, 2005
Jkt 208001
or by e-mail to niocindocket@cdc.gov. Email attachments should be formatted in
Microsoft Word. Comments should be
submitted to NIOSH no later than March
31, 2006, and should reference docket
number NIOSH–033 in the subject
heading.
Oral comments made at the public
meeting must also be submitted to the
docket in writing in order to be
considered by the Agency.
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
Docket Office, Room 111, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
Contact Persons For Technical
Information: Christine Sofge 513/533–
8439 or Faye Rice 513/533–8335, M/S
C–15, Robert A. Taft Laboratories, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: December 22, 2005.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E5–8100 Filed 12–29–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10157, CMS–
10172, CMS–R–0107 and CMS–R–285]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
AGENCY:
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: CMS Real-time
Eligibility Agreement and Access
Request; Form Number: CMS–10157
(OMB#: 0938–0960); Use: Federal law
requires that CMS take precautions to
minimize the security risk to Federal
information systems. Accordingly, CMS
is requiring that trading partners who
wish to conduct the eligibility
transaction on a real-time basis to access
Medicare beneficiary information
provide certain assurances as a
condition of receiving access to the
Medicare database for the purpose of
conducting eligibility verification.
Health care providers, clearinghouses,
and health plans that wish access to the
Medicare database are required to
complete this form. The information
will be used to assure that those entities
that access the Medicare database are
aware of applicable provisions and
penalties; Frequency: Recordkeeping
and Reporting—One time; Affected
Public: Business or other for-profit, Notfor-profit institutions; Number of
Respondents: 122,000; Total Annual
Responses: 122,000; Total Annual
Hours: 45,000.
2. Type of Information Collection
Request: New Collection; Title of
Information Collection: Medicare Health
Support Program Medical Records
Abstraction; Form Number: CMS–10172
(OMB#: 0938–New); Use: The Medicare
Health Support Program (MHS) is
authorized under Section 721 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA). There are eight Medicare
Health Support Organizations (MHSOs)
that have signed cooperative agreements
with the Centers for Medicare &
Medicaid Services (CMS) to provide
care support services to targeted
Medicare fee-for-service (FFS)
beneficiaries. The purposes of the MHS
program are to improve the quality of
healthcare provided to Medicare FFS
beneficiaries with congestive heart
failure and/or diabetes and to reduce the
healthcare treatment cost to Medicare.
MHS performance measures provide
CMS with information to monitor the
program operations and identify
positive or negative program effects,
provide MHSOs with feedback, and
E:\FR\FM\30DEN1.SGM
30DEN1
]]>Agencies
[Federal Register Volume 70, Number 250 (Friday, December 30, 2005)]
[Notices]
[Pages 77399-77400]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-8100]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health (NIOSH) of
the Centers for Disease Control and Prevention (CDC) Announces the
Following Meeting and Opening of the Public Comment Period
Name: The Draft Document: NIOSH Current Intelligence
Bulletin: Evaluation of Health Hazard and Recommendations for
Occupational Exposure to Titanium Dioxide.
Meeting Date and Time: February 27, 2006, 9 a.m.-4 p.m.
Place: Robert A. Taft Laboratories, Taft Auditorium, NIOSH, CDC,
4676 Columbia Parkway, Cincinnati, Ohio 45226.
Purpose: To explain and discuss the scientific basis for the draft
document, ``NIOSH Current Intelligence Bulletin: Evaluation of Health
Hazard and Recommendations for Occupational Exposure to Titanium
Dioxide,'' current research on titanium dioxide, and information on
occupational exposure to titanium dioxide. Special emphasis will be
placed on discussion of the following:
(1) What animal and human data best describe the health concerns
from exposure to titanium dioxide; (2) What strategies are being used
to control occupational exposure to titanium dioxide (e.g., engineering
controls, work practices, personal protective equipment); (3) In which
workplaces and occupations can exposure to titanium dioxide occur; (4)
What challenges exist in measuring workplace exposures to titanium
dioxide; (5) What are areas for future collaborative efforts (e.g.,
research, communication, development of exposure measurement and
control strategies)?
The public is invited to attend and will have the opportunity to
provide comments.
NIOSH seeks to obtain materials, including published and
unpublished reports and research findings, to evaluate the possible
health risks of occupational exposure to titanium dioxide (including
particle size-specific information). Examples of requested information
include, but are not to be limited to, the following: (1)
Identification of industries or occupations in which exposures to
titanium dioxide may occur; (2) Trends in the production and use of
titanium dioxide; (3) Description of work tasks and scenarios with a
potential for exposure to titanium dioxide; (4) Current and historical
exposure measurement data in various types of industries and jobs; (5)
Case reports or other health information demonstrating health effects
in workers exposed to titanium dioxide; (6) Reports of experimental in
vivo and in vitro studies that provide evidence of a dose-relationship
between the particle size of a substance and its biological activity;
(7) Reports of experimental inhalation studies with rodents
demonstrating a relationship between the particle size or surface area
of a substance and lung inflammation, fibrosis, and biochemical
mediators; (8) Description of work practices and engineering controls
used to reduce or prevent workplace exposure to titanium dioxide. (9)
[[Page 77400]]
Educational materials for worker safety and training on the safe
handling of titanium dioxide; (10) Data pertaining to the feasibility
of establishing particle size-specific RELs for titanium dioxide.
NIOSH will use this information to assess the scientific basis for
the draft worker health recommendations contained in the draft Current
Intelligence Bulletin and determine the need for revision to those
draft recommendations for reducing occupational exposure to titanium
dioxide.
Status: The forum will include scientists and representatives from
various government agencies, industry, labor, and other stakeholders,
and is open to the public, limited only by the space available. The
meeting room accommodates 80 people. Due to limited space, notification
of intent to attend the meeting must be made to Diane Miller no later
than February 14, 2006. Ms. Miller can be reached by telephone at 513/
533-8450 or by e-mail at niocindocket@cdc.gov. Requests to attend the
meeting will be accommodated on a first-come basis.
Non-U.S. Citizens: Because of CDC Security Regulations, any non-
U.S. citizen wishing to attend this meeting must provide the following
information in writing to Diane Miller at the address below no later
than February 14, 2006: (1) Visitor's full name; (2) Gender; (3) Date
of Birth; (4) Place of birth (city, province, state, country); (5)
Citizenship; (6) Passport number; (7) Date of passport issue; (8) Date
of passport expiration; (9) Type of Visa; (10) Visitor's organization;
(11) Organization address; (12) Organization telephone number; (13)
Visitor's position/title within the organization.
This information will be transmitted to the CDC Security Office for
approval. Visitors will be notified as soon as approval has been
obtained.
A copy of the draft Current Intelligence Bulletin Evaluation of
Health Hazard and Recommendations for Occupational Exposure to Titanium
Dioxide can be obtained from the Internet at https://www.cdc.gov/niosh/
docs/preprint/tio2 or a hard copy may be requested from the Docket
Officer, Diane Miller (contact information below).
Addresses: Comments should be submitted to the NIOSH Docket Office,
ATTN: Diane Miller, Robert A. Taft Laboratories, 4676 Columbia Parkway,
M/S C-34, Cincinnati, Ohio 45226, telephone 513/533-8450, fax 513/533-
8285.
Comments may also be submitted directly through the Web site
(https://www.cdc.gov/niosh/docs/preprint/tio2) or by e-mail to
niocindocket@cdc.gov. E-mail attachments should be formatted in
Microsoft Word. Comments should be submitted to NIOSH no later than
March 31, 2006, and should reference docket number NIOSH-033 in the
subject heading.
Oral comments made at the public meeting must also be submitted to
the docket in writing in order to be considered by the Agency.
All information received in response to this notice will be
available for public examination and copying at the NIOSH Docket
Office, Room 111, 4676 Columbia Parkway, Cincinnati, Ohio 45226.
Contact Persons For Technical Information: Christine Sofge 513/533-
8439 or Faye Rice 513/533-8335, M/S C-15, Robert A. Taft Laboratories,
4676 Columbia Parkway, Cincinnati, Ohio 45226.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: December 22, 2005.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E5-8100 Filed 12-29-05; 8:45 am]
BILLING CODE 4163-18-P
